Carl Zeiss Meditec receives FDA clearance for INTRABEAM 700 (€52.05, -0.90)
StreetAccount Summary - Trading higher/lower: EU mid-morning
Carl Zeiss Meditec upgraded to buy from neutral at Goldman Sachs (€58.35, 0.00)
Carl Zeiss Meditec trading lower; placed on Negative Catalyst Watch at JPMorgan (€60.75, 0.00)
Powered by FactSet Research Systems Inc.